These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4042077)

  • 1. The human B-cell lineage cell line ARH-77.
    Ralph P
    Cancer; 1985 Nov; 56(10):2544-5. PubMed ID: 4042077
    [No Abstract]   [Full Text] [Related]  

  • 2. Solitary and multiple plasmacytoma.
    Kraj M; Maj S; Wroński D; Letowska M
    Acta Med Pol; 1982; 23(1-2):91-103. PubMed ID: 7187604
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloma cells: surface morphology as seen by scanning and transmission electron microscopy.
    Polliack A; Gamliel H; Froimovici M; Laskov R
    Isr J Med Sci; 1978 Dec; 14(12):1252-8. PubMed ID: 748237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a human plasma cell line in vitro.
    Burk KH; Drewinko B; Turjillo JM; Ahearn MJ
    Cancer Res; 1978 Aug; 38(8):2508-13. PubMed ID: 566614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
    Nahi H; Genell A; Wålinder G; Uttervall K; Juliusson G; Karin F; Hansson M; Svensson R; Linder O; Carlson K; Björkstrand B; Kristinsson SY; Mellqvist UH; Blimark C; Turesson I
    Eur J Haematol; 2017 Sep; 99(3):216-222. PubMed ID: 28544116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant lymphomas of B-cell type.
    Stein H; Lennert K; Parwaresch MR
    Lancet; 1972 Oct; 2(7782):855-7. PubMed ID: 4116558
    [No Abstract]   [Full Text] [Related]  

  • 7. Parasellar syndrome caused by plasma cell leukemia.
    Bellan LD; Cox TA; Gascoyne RD
    Can J Ophthalmol; 1989 Dec; 24(7):331-4. PubMed ID: 2624915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma cell leukemia with amyloid deposition and osteogenetic change at the site of an extramedullary plasmacytoma].
    Kurosu T; Sakashita C; Yamamoto K; Tohda S; Miki T; Koyama T; Miura O; Murakami N; Nemoto T; Miyasaka N; Kamiyama R; Hirosawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):58-63. PubMed ID: 9028163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sigmoid localization of Kahler's disease. Acute terminal plasmacytic leukemia with gastric and duodenal localizations].
    Poulet J; Cocheton JJ; Combrisson A; Rolland J
    Sem Hop; 1974 Nov 20-26; 50(47-48):2923-7. PubMed ID: 4376615
    [No Abstract]   [Full Text] [Related]  

  • 10. Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin.
    Karpas A; Fisher P; Swirsky D
    Lancet; 1982 Apr; 1(8278):931-3. PubMed ID: 6122771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.
    Huang YW; Richardson JA; Tong AW; Zhang BQ; Stone MJ; Vitetta ES
    Cancer Res; 1993 Mar; 53(6):1392-6. PubMed ID: 8443818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of cutaneous plasmacytoma to plasma cell leukemia in a dog.
    Rout ED; Shank AM; Waite AH; Siegel A; Avery AC; Avery PR
    Vet Clin Pathol; 2017 Mar; 46(1):77-84. PubMed ID: 28186653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant monoclonal gammopathies.
    Carney DN; Bunn PA
    Prim Care; 1980 Sep; 7(3):369-94. PubMed ID: 6777792
    [No Abstract]   [Full Text] [Related]  

  • 15. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo model of human multiple myeloma bone disease.
    Alsina M; Boyce BF; Mundy GR; Roodman GD
    Stem Cells; 1995 Aug; 13 Suppl 2():48-50. PubMed ID: 8520511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell myelomatosis and other monoclonal gammapathies.
    Azar HA
    Pathol Annu; 1972; 7():1-17. PubMed ID: 4114603
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple myeloma: a proper selection of the treatment regimen for an individual patient].
    Kanoh T
    Nihon Rinsho; 1995 Mar; 53(3):671-7. PubMed ID: 7699903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
    Huang YW; Richardson JA; Vitetta ES
    Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma.
    Strickler JG; Audeh MW; Copenhaver CM; Warnke RA
    Cancer; 1988 May; 61(9):1782-6. PubMed ID: 3355976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.